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Abstract
Objective: Bone marrow (BM) is one of the major hematopoietic organs in postnatal life that 
consists of a heterogeneous population of stem cells which have been previously described. 
Recently, a rare population of stem cells that are called very small embryonic-like (VSEL) stem 
cells has been found in the BM. These cells express several developmental markers of pluri-
potent stem cells and can be mobilized into peripheral blood (PB) in response to tissue injury. 
In this study we have attempted to investigate the ability of these cells to migrate toward an 
injured spinal cord after transplantation through the tail vein in a rat model. 
Materials and Methods: In this experimental study, VSELs were isolated from total BM 
cells using a fluorescent activated cell sorting (FACS) system and sca1 and stage specific 
embryonic antigen (SSEA-1) antibodies. After isolation, VSELs were cultured for 7 days 
on C2C12 as the feeder layer. Then, VSELs were labeled with 1,1´-dioctadecyl-3,3,3´,3´-
tetramethylindocarbocyanine perchlorate (DiI) and transplanted into the rat spinal cord 
injury (SCI) model via the tail vein.  Finally, we sought to determine the presence of VSELs 
in the lesion site.    
Results: We isolated a high number of VSELs from the BM. After cultivation, the VSELs 
colonies were positive for SSEA-1, Oct4 and Sca1. At one month after transplantation, 
real-time polymerase chain reaction analysis confirmed a significantly increased expres-
sion level of Oct4 and SSEA-1 positive cells at the injury site.                   
Conclusion: VSELs have the capability to migrate and localize in an injured spinal 
cord after transplantation.      
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Introduction
Spinal cord injury (SCI) is a neurological condition 
that results in disability and dysfunction, inducing 
inflammatory responses throughout the injuredarea. 
This response acts not only on the inflammatory cells 
that migrate toward the damaged area, but also on in-
creases the plasma chemokine levels. In response to 
these chemotactic factors, circulating cells such as 
granulocytes, lymphocytes, and monocytes increase 
in peripheral blood (PB) (1, 2). Previous studies have 
shown that in addition to hematopoietic stem cells 
(HSCs), bone marrow (BM) contains a population of 
non-HSCs that can be mobilized into PB after myo-
cardial infarctions (MI) (3) and strokes (4). These 
cells, very small embryonic-like (VSEL) stem cells, 
(5) are characterized by their very small size, large 
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nuclei surrounded by a narrow rim of cytoplasm, and 
open-type euchromatin (6). VSEL stem cells express 
markers found in pluripotent stem cells such as stage 
specific embryonic antigen (SSEA), Oct-4, and Na-
nog, in addition to ahigh telomerase activity and ca-
pability to differentiate into cells from all three germ-
layers (7). Interestingly, these cells express primordial 
germ cell features such as C-X-C chemokine receptor 
type 4 (CXCR4), Stella and Fragilis. VSEL stem cells 
appear to be the progeny of epiblast cells (5).
In addition to the BM, VSEL stem cells are present 
in cord blood (8), the heart, and brain. Probably this 
population of cells are deposited during early organo-
genesis in developing organs and play an important 
role in postnatal tissue turnover and regeneration (9).
Recently, a number of studies have focused on non-
HSCs for the regeneration of damaged tissue.
In a mouse model of MI, intramyocardial injection 
of VSELs showed promising effects. VSELs could 
improve myocardial contractility and were more ef-
fective than HSCs (10). Their  small size might enable 
their use as a unique source for cell therapy in neuro-
logical disorders such as strokes (11).
Since CXCR4 is expressed on VSELs, these 
cells could migrate to the stromal derived factor-1 
(SDF-1) gradient. SDF-1 is one of the most impor-
tant chemokines that upregulates in damaged tissue. 
This chemokine regulates the trafficking of CXCR4 
positive cells to tissue affected by inflammation. The 
SDF-1/CXCR4 axis plays pivotal roles in mobiliza-
tion of progenitor stem cells during embryogenesis 
and tissue regeneration (12).
 This study used VSELs to regenerate a SCI from 
a rat model. We transplanted VSEL stem cells by in-
travenous injection into this rat model of SCI in order 
to determine if these transplanted cells could migrate 
into the lesion site.
Materials and Methods
This experimental study was conducted according 
to the Guidelines of Iran University of Medical Sci-
ences for Animal Care and approved by the Ethics 
Committeeat Iran University of Medical Sciences.
Bone marrow cells
BM  cells were collected from the femur and tibia 
of 2-4 week-old male National Medical Research In-
stitute (NMRI) mice (Iran University, Iran) by vigor-
ous flushing with Dulbecco’s modified Eagle’s me-
dium (DMEM, Invitrogen, USA). Erythrocytes were 
removed with erythrocyte lysis buffer (Dako, USA).
Bone marrow-derived cell sorting
Sca+ and SSEA-1+ cells were isolated from a sus-
pension of murine BM by multiparameter fluores-
cence activated cell sorting (FACS, Aria II-BD, 
Becton Dickinson, USA) according to standard 
procedures. Briefly, BM cells were resuspended in 
phosphate buffered saline (PBS, Invitrogen, USA) 
with 2% heat-inactivated fetal bovine serum (FBS, 
Gibco, USA). The following antibodies were used to 
stain these cells: fluoresceinisothiocyanate (FITC)-
anti-Sca1 (Ly6A/E, 1:100, Abcam, USA) and anti-
SSEA-1(1:100, Abcam, USA). Cells were incubated 
on ice for 30-45 minutes and washed twice, after 
whichgoat anti-mouse labeled with phycoerythrin 
(PE, 1:100, Abcam, USA) was added for 1 hour as 
the secondary antibody for SSEA-1. Finally, the cells 
were washed and resuspended for sorting in PBS/FBS 
at a concentration of 5-10×106 cells/ml.
Cell culture and expansion 
Freshly sorted VSELs were cultured over C2C12 
murine myoblast cell feeder layer that inactivated 
with mitomycin C in DMEM/F12 (Invitrogen, USA) 
supplemented with 20% FBS, 1X non-essential 
amino acids (NEAA, Invitrogen, USA), 50 mMbeta-
2mercaptoethanol (2ME, Invitrogen, USA), 2 mM L-
glutamine (Invitrogen, USA) and 103 U/ml leukemia 
inhibitory factor (LIF, Sigma, Germany) at 37˚C in 
humidified atmosphere of 5% CO2 in air. VSELs were 
expanded for 7 days with a change of medium every 
3-4 days.
Immunocytochemistry 
The cells were fixed with 4% paraformaldehyde 
(Sigma, Germany), and then permeabilized by 
0.1% Triton X-100 (Sigma, Germany). Nonspe-
cific binding was blocked by goat serum (Sigma, 
Germany). The following combinations of prima-
ry and secondary antibodies were used for double 
staining: FITC anti-Sca1, anti-SSEA-1, and goat 
anti-mouse labeled with PE (1:100, Abcam, USA, 
vs. anti-SSEA-1). Cells were incubated overnight 
with primary antibody at 4˚C. After washing, cells 
were incubated with secondary antibodies for 1 
hour at room temperature. The nuclei were coun-
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terstained with Hoechst stain (Sigma, Germany).
Animals
The animals, 12-week-old male Wistar rats (250-
300 g) were maintained in a pathogen-free and 
climate-controlled environment with free access 
to water and food. Rats were kept at a temperature 
of 20˚C and exposed to alternate 12 hour light and 
dark cycles. We randomly divided the animals into 
the following 4 groups (n=5 per group) prior to 
the surgical procedure: SCI with VSEL treatment 
(experimental group), SCI with C2C12 treatment 
(vehicle group), SCI without any treatment (sham 
group), and normal animals with no SCI that re-
ceived VSEL treatment (control group).
Spinal cord injury procedure
Each ratwas deeply anesthetized via an intraperito-
neal injection of ketamine and xylazine (80.5 mg/kg, 
Razi Co., Iran). The animals were placed in the prone 
position and surgery was performed under sterile con-
ditions. The surgical area was shaved and disinfected 
with a povidone iodine solution. A skin incision and 
blunt dissection of the muscle layers over the area 
were performed. The clip compression injury was per-
formed at the region of the 9th-10th thoracic segment 
by removal of the dorsal processes of the 9th and 10th 
thoracic vertebrae. The spinal cord was compressed 
for 1 minute dorsoventrally (13, 14). The animals 
received postoperative care that included  Ringer’s 
lactate solution (1 ml, subcutaneously) for 7 days and 
penicillin/streptomycin (intramuscularly, Invitrogen, 
USA) for 3 days. Additionally, the rats’bladders were 
manually expressedtwice per day until the return of 
the bladder reflex.
Transplantation
VSELs were labeled with the fluorescent lipophilic trac-
er 1,1´-dioctadecyl-3,3,3´,3´-tetramethylindocarbocyanine 
perchlorate (DiI, Invitrogen, USA) according to the manu-
facturer’s protocol. Briefly, cells were incubated in 1 μg/
mL DiI solution for 20 minutes at 37˚C. After incubation, 
cells were washed and resuspended in PBS. At 7 days af-
ter the SCI, 1×106 cells/200 μl were injected intravenously 
through the tail vein. All animals were sacrificed 28 days 
after treatment.
Tissue preparation and immunohistochemistry
Rats were deeply anesthetized with ketamine and 
xylazine, then transcardially perfused with 150-200 
ml PBS followed by 4% paraformaldehyde. The spi-
nal cord was dissected and maintained for two days in 
4% paraformaldehyde. Fixed samples were harvested 
for subsequent histological processing. Tissue speci-
mens were embedded in paraffin (Merck, Germany) 
and 5 mm paraffin sections were transversely cut. 
For immunofluorescence studies, after deparaffiniza-
tion and antigen retrieval, we rinsed the sections with 
PBS. Next, the sections were treated with blocking 
solution and incubated overnight with anti-SSEA-1 at 
4˚C. The next day after washing with PBS, the secs-
tions were incubated with the secondary antibody, 
goat anti-mouse (1:1000, Abcam, USA), for 2 hours 
at room temperature. Sections were washed in PBS, 
and then nuclei were counterstained with Hoechst for 
45 minutes and mounted on glass slides.
Real-time reverse transcriptase-polymerase chain 
reaction (RT-PCR)
We analyzed Oct4 mRNA levels by isolating total 
mRNA from spinal cord tissue with Trizol reagent 
(Invitrogen, USA) according to the manufacturer’s 
instructions. mRNA was reverse-transcribed with a 
cDNA synthesis kit (Roche, USA). Detection of Oct4 
mRNA levels was performed by real-time RT-PCR 
using an ABI PRISMs 7000 Sequence Detection Sys-
tem (ABI, USA). The 25 µl reaction mixture contained 
12.5 µl SYBR Green PCR Master Mix, 10 ng of cDNA 
template, and 5ˊ-TGGGGCGGTTTTGAGTAATCT-3ˊ 
forward and 5ˊ- CTCTTCTGCTTCAGCAGCTTG-3ˊ 
reverse primers for Oct4. These primers were designed 
on the basis of areaction with mouse cells. The threshold 
cycle (Ct) or the cycle number at which the amount of 
amplified gene of interest reached a fixed threshold 
was subsequently determined.
We have calculated the relative relative quanti-
fication of Oct4 mRNA expression according to 
the comparative Ct method. The relative quanti-
ficationvalue of the target, normalized to an en-
dogenous control β-actin gene and relative to a 
calibrator, is expressed as 2-ΔΔCt (fold difference) 
where ΔCt equals the Ct of the target gene minus 
the Ct of the endogenous control gene (β-actin). 
Reactions have been performed with appropriate 
negative controls (template-free) and a uniform 
amplification of the products was rechecked by 
an analysis of the melting curves of the amplified 
products. The melting temperature (Tm) was 57-
60˚C. Gel electrophoresis was performed to con -
firm the correct size of the amplification and the 
absence of unspecific bands.
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Statistical analysis
Results were expressed as mean ± SD. The sta-
tistical significance between the mean values was 
determined by one-way ANOVA followed by Tuk-
ey’s post-test with P<0.05 as the statistically sig-
nificant criterion.
Results
Isolation and expansion of very small embryonic-
like stem cells
We employed multiparameter analysis to isolate 
VSELs from BM. After flushing the BM cavity, 
VSELs were isolated using Sca1 and SSEA-1 an-
tibodies and FACS. Reanalysis of sorted cell frac-
tions showed a purity of >95% (Fig.1).
Freshly isolated VSELs were expanded by cul-
turing them on a C2C12 myoblast feeder layer. 
After 4-7 days, cells began to form sphere-like 
clusters that consisted of a few hundred cells 
which resembled embryoid bodies (Fig.2). These 
colonies were immunopositive for both Sca1 and 
SSEA-1 which indicated that the colonies were 
composed mainly of VSELs (Fig.3).
Fig.1: Fluorescent activated cell sorting (FACS) analysis for the isolation of very small embryonic-like (VSELs) stem cells from total bone 
marrow (BM) cells. Sorting was based on the immunophenotype [Sca1+ and stage specific embryonic antigen (SSEA-1+)] of the VSELs. 
Events contained the presence of Sca1 and SSEA-1 (gate Q2), which represented the population of VSELs.
Fig.2: Morphology of very small embryonic-like (VSEL) stem cells derived from 2-4 week-old mice. After 7 days, VSELs began to form 
sphere-like clusters. 
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Fig.3: A-D. Characterization of very small embryonic-like (VSEL) stem cell colonies by double staining. VSEL colonies were positive for both 
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Fig.4: A-C. Cross-section of spinal cord at 4 weeks after very small embryonic-like (VSEL) stem cell transplantation. More labeled VSELs 
were detected in the dorsal columns of the spinal cords of experimental rats, D-F. Compared with control rats, G-I. Only a few labeled 
cells were detected in the uninjured site of the experimental rats and J-L. There were no labeled cells within the spinal cords of the sham 
group. A, D, G, J. Labeled VSELs with 1,1`-dioctadecyl-3,3,3`,3`-tetramethylindocarbocyanine perchlorate (DiI), B, E, H, K. Hoechst positive 
nuclei, C, F, I and L. Merged. 
Transplantation and survival of very small 
embryonic-like stem cells into the lesion site
We determinedthe ability of VSELs to efficiently 
home to the lesion site. After one month, the lesion 
site was analyzed in the rats that received VSELs. In 
these rats, we detected the labeled VSELs at the lesion 
site (Fig.4). Real time RT-PCR results showed a sig-
nificantly increased Oct4 expression level (P≤0.05) in 
the SCI group treated with VSELs (Fig.5).
We verified the successful homing of the VSELs 
by analyzing spinal cord tissues for SSEA-1 which 
recognizes the VSEL surface marker. SSEA-1 was 
strongly detected in the group transplanted with VS-
ELs. This result implied that VSELs had migrated 
into the injured spinal cord via the peripheral circula-
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Fig.5: Expression pattern of Oct4 at one month after transplantation as analyzed by real time RT-PCR. The level of Oct4 significantly in-
creased in the injured site of the experimental group. Data show means ± SD, *; P≤0.05 and RT-PCR; Reverse transcriptase polymerase 
chain reaction.
Fig.6: A. Stage specific embryonic antigen (SSEA-1+) cells in the dorsal funiculus of the spinal cord  in the experimental, B. Control, C. 
Uninjured site of experimental and D. Sham groups. Note; There were more SSEA-1+ cells in the experimental group compared to the 





646CELL JOURNAL(Yakhteh), Vol 17, No 4, Jan-Mar (Winter) 2016     
VSELs Could Migrate toward The Injured Spinal Cord
Discussion
We have transplanted VSELs into the tail veins 
of rats wherethese cells showed their ability to 
move toward the injured spinal cord. It is esti-
mated that more than 2.5 million people live with 
SCI and 130,000 new cases are reported each year. 
Stem cell therapy is a promising treatment for SCI 
(15). Kucia et al. (7) have recently discovered a 
new population of stem cells (VSELs) in BM. A 
major problem with VSELs is the rare occurrence 
of these particular cells in BM - as low as 0.05% 
of total BM cells in mice (16). We have used 2-4 
week-old mice in this study in order to isolate VS-
ELs. The numbers of VSELs decrease with age 
and the expression levels of pluripotent markers is 
higher in VSELs from young animalse (17).
In this study we enriched VSELs  by FACS us-
ing SSEA-1 and Sca1 antibodies. Evaluation of 
the purity of the VSELs preparation demonstrated 
that this procedure was very effective for VSEL 
isolation. Other studies evaluated this method 
when producing VSELs from cord blood as well 
as PB (8, 18). When VSELs culture without any 
feeder layer or inhibitor, like embryonic stem cells 
can  differentiate spontaneously, thus in this study 
we used C2C12 feeder layer cells to inhibit their 
spontaneously differentiation (19). During cultiva-
tion, VSELs started colony formation and largely 
expressed SSEA-1, Sca1 and Oct4. These develop-
mental criteria suggested the proliferation of VS-
ELs into a pluripotent phenotype.
We have transplanted labeled VSELs through 
the tail veins of rats. There are several routes for 
cell transplantation such as: local (directly into the 
ischemic area), intra-arterial, epidural and intrave-
nous (IV) infusion. Among these, site-directed de-
livery of cells provides effective engraftment, how-
ever it is not always applicable in clinical practice. 
IV injection is minimally invasive and the majority 
of injected cells reach their target (20). Previous stud-
ies have described the IV route of cell administration 
and shown this methodto be the most convenient for 
cell transplantation (21-24).
In the present study, we established that intra-
venously administered VSELs have the ability to 
move towards the lesion site. Another important 
observation during this study was that the expres-
sion level of Oct4 increased after transplantation 
of VSELs into the lesion. In parallel, immuno-
histochemical studies demonstrated that SSEA-1 
positive cells localized into the injured spinal cord 
in the VSEL treated animals.
Evidence has shown that VSELs mobilize in  PB 
in response to myocardial ischemia (3), stroke (4, 
10) and skin burn injury (25). The quiescent VS-
ELs can rapidly proliferate and mobilize with in-
creased migration from their resident BM or other 
tissue to the blood circulation in response to injury 
(26). A key chemokine involved in this mobiliza-
tion is SDF-1 (also termed CXCL12) which acts 
via its major receptor, CXCR4 that expresses  on 
VSELs. These cells respond to the upregulation 
of SDF-1 within injured organs and migrate into 
these areas (12).
Cell therapy for spinal cord repair has generated 
considerable enthusiasm in recent years and differ-
ent types of cells have been used for this purpose 
(15). In view of the ability of VSELs to express 
neural (GFAP, Nestin, b-III tubulin, Olig1, Olig2, 
Sox2, and Musashi-1) stem cell markers in PB-
borne nucleated cellsthat circulate  in stroke pa-
tients as well as in a murine model of stroke, we 
believe that VSELs which colonize  in the injured 
spinal cord may be involved in SCI regeneration. 
However, the potential use of these cells in spinal 
cord tissue regeneration requires further study.
Conclusion
The present study indicated that transplanted 
VSELs could migrate via PB and localize in the 
injured spinal cord. Hence, VSELs might be a 
therapeutic option for SCI patients. 
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